Corpus Intelligence IC Memo — VIBRA HOSPITAL OF BOISE 2026-04-26 07:43 UTC
IC Memo — VIBRA HOSPITAL OF BOISE
Investment Committee Memorandum | ID | 40 beds | Grade C | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

VIBRA HOSPITAL OF BOISE

CCN 132002 | ADA, ID | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

VIBRA HOSPITAL OF BOISE is a 40-bed safety-net/medicaid heavy in ADA, ID with $19.1M in net patient revenue and a -3.3% operating margin. The hospital serves a payer mix of 32.0% Medicare, 28.6% Medicaid, and 39.4% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.3% to 4.1% (+736bps).

Net Revenue HCRIS$19.1M
Current EBITDA COMPUTED$-628K
Operating Margin COMPUTED-3.3%
Occupancy HCRIS71.3%
Revenue / Bed COMPUTED$478K
Net-to-Gross HCRIS49.1%
Distress Probability ML52.5%

2. Market Context & Competitive Position

51
ID Hospitals
-3.5%
State Median Margin
22
Comparable Hospitals

ID has 51 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -3.3% places it above the state median. Among 22 size-comparable peers (20-80 beds), the median margin is -2.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 22 hospitals in the comp set.

HospitalStateBedsRevenueMargin
VIBRA HOSPITAL OF BOISE (Target)ID40$19.1M-3.3%
MOUNTAIN VIEW HOSPITALID43$382.5M8.7%
BINGHAM MEMORIAL HOSPITALID25$164.8M-3.6%
NORTHWEST SPECIALTY HOSPITALID32$120.3M3.7%
TREASURE VALLEY HOSPITALID28$114.8M36.1%
ST. LUKES WOOD RIVER MEDICAL CID25$99.1M13.5%
MADISON MEMORIAL HOSPITALID53$94.0M1.1%
GRITMAN MEDICAL CENTERID25$92.4M-6.4%
BONNER GENERAL HOSPITALID25$61.2M-7.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$401K+210bp18mo
Cost to Collect4.5%2.5%$382K+200bp12mo
Denial Rate Reduction12.0%6.5%$378K+198bp12mo
A/R Days Reduction5200.0%3800.0%$232K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$401K
Cost to Collect
$382K
Denial Rate Reduction
$378K
A/R Days Reduction
$232K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$-628K
+ RCM Uplift+$1.4M
Pro Forma EBITDA$778K
Current Margin-3.3%
Pro Forma Margin4.1%
WC Released (1x)$733K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-967K$9.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-967K$10.6M0.00x-100.0%
Bull Case9.0x11.0x$-870K$14.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-870K$16.0M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$3.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$3.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (28.6%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 52.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 22 hospitals with 20-80 beds
  • Same-state prioritization (n=23)
  • Comp margins: P25=-6.2% / P50=-2.3% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.